Related Experiment Video
Updated: Nov 14, 2025
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
5.5K
Antithrombotic treatment in primary percutaneous coronary intervention
Felix Voll1, Constantin Kuna1, Gjin Ndrepepa1
1Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
Expert Review of Cardiovascular Therapy
|March 11, 2021
Summary
Optimal antithrombotic therapy for ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) requires balancing bleeding and clotting risks. Early antiplatelet and anticoagulation, followed by tailored long-term treatment, improves outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) face elevated risks of adverse cardiovascular events.
- Guideline-directed antithrombotic therapy effectively reduces these risks, yet improvements are still needed.
Purpose of the Study:
- To review current data on antithrombotic therapy in STEMI patients undergoing pPCI.
- To discuss strategies for optimizing antithrombotic treatment in this high-risk population.
Main Methods:
- Literature review of current data on antithrombotic therapy in STEMI patients undergoing pPCI.
Main Results:
- Early administration of antiplatelet agents and anticoagulation is crucial for achieving adequate antithrombotic effect during pPCI.
- Long-term antithrombotic strategies should be individualized based on patient-specific thrombotic and bleeding risks.
Conclusions:
- Antithrombotic therapy must address both short-term and long-term risks of thrombosis and bleeding in STEMI patients post-pPCI.
- Tailoring therapy ensures adequate secondary ischemic prevention while minimizing excess bleeding complications.
Keywords:
anticoagulation therapyaspirinclopidogrelcoronary artery diseasedual antiplatelet therapypercutaneous coronary interventionprasugrelticagrelorMore Related Videos
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
107
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
107
01:29Venous Thrombosis III: Interprofessional Care
103
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
103
01:28Acute Coronary Syndrome IV: Interprofessional Care
89
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
89
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
829
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
829
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
108
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
108
01:27Coronary Artery Disease V: Interprofessional Care
115
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
115